Previous Treatment in Main Study | |||
---|---|---|---|
Total Group | Ovaleap® | Gonal-f® | |
Cycle 2 | |||
Biochemical pregnancy, n/N (%) | 46/147 (31.0) | 24/80 (30.0) | 22/67 (32.8) |
Ongoing pregnancya, n/N (%) | 37/143 (25.9) | 21/79 (26.6) | 16/64 (25.0) |
Cycle 3 | |||
Biochemical pregnancy, n/N (%) | 19/61 (31.0) | 10/34 (29.4) | 9/27 (33.3) |
Ongoing pregnancya, n/N (%) | 13/60 (21.7) | 8/33 (24.2) | 5/27 (18.5) |
Combined Cycles 2 and 3 | |||
Biochemical pregnancy, n/N (%) | 63/147 (42.9) | 33/80 (41.3) | 30/67 (44.8) |
Ongoing pregnancya, n/N (%) | 50/144 (34.7) | 29/80 (36.3) | 21/64 (32.8) |